Gene expression profiling in microdissected primary cHL samples revealed changes in the regulation of pathways (e.g., JAK-STAT and NFκB) known to drive the pathogenesis of cHL (19). The gene discussed is NFKB1; the disease is classic Hodgkin lymphoma.